NOTCH1 and lung adenocarcinoma: Furthermore, it has been shown that gefitinib-acquired resistant lung adenocarcinoma cells undergo EMT by activation of Notch-1 signaling via Notch-1 receptor intracellular domain (N1IC), the activated form of the Notch-1 receptor [63].